Tissue microarray of prostate cancer: successful survival stratification based on the heterogeneously distributed tumour markers Bcl-2 and Ki67

被引：0
|
作者：
Fleischmann, A. [1 ]
Schlomm, T. [1 ]
Huland, H. [1 ]
Mirlacher, M. [1 ]
Simon, R. [1 ]
Sauter, G. [1 ]
Erbersdobler, A. [1 ]
机构：
[1] Univ Bern, Inst Pathol, Bern, Switzerland
来源：
VIRCHOWS ARCHIV | 2009年 / 455卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [21] Correlation between Proliferation Markers: PCNA, Ki-67, MCM-2 and Antiapoptotic Protein Bcl-2 in Colorectal Cancer
    Guzinska-Ustymowicz, Katarzyna
    Pryczynicz, Anna
    Kemona, Andrzej
    Czyzewska, Jolanta
    ANTICANCER RESEARCH, 2009, 29 (08) : 3049 - 3052
  • [22] A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer
    Ali, H. Raza
    Dawson, Sarah-Jane
    Blows, Fiona M.
    Provenzano, Elena
    Leung, Samuel
    Nielsen, Torsten
    Pharoah, Paul D.
    Caldas, Carlos
    JOURNAL OF PATHOLOGY, 2012, 226 (01): : 97 - 107
  • [23] Immunohistochemical analysis of Ki-67 antigen and Bcl-2 protein expression in prostate cancer: effect of neoadjuvant hormonal therapy
    Tsuji, M
    Murakami, Y
    Kanayama, H
    Sano, T
    Kagawa, S
    BRITISH JOURNAL OF UROLOGY, 1998, 81 (01): : 116 - 121
  • [24] The influence of IPI, Ki67 and Bcl-2, on survival in patients with DLBCL treated with R-CHOP regimen - Serbian lymphoma study group experience
    Jovanovic, M. Perunicic
    Jakovic, Lj.
    Terzic, T.
    Gotic, M.
    Jankovic, S.
    Sretenovic, A.
    Petrovic, M.
    Boskovic, D.
    Mihaljevic, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 525 - 525
  • [25] Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification
    Jurmeister, Philipp
    Bockmayr, Michael
    Treese, Christoph
    Stein, Ulrike
    Lenze, Dido
    Joehrens, Korinna
    Friedling, Franziska
    Dietel, Manfred
    Klauschen, Frederick
    Marsch, Wolfgang
    Fiedler, Eckhard
    von Laffert, Maximilian
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (08): : 800 - 809
  • [26] Expression of topoisomerase II, BCL-2, and Ki-67 in ovarian cancer tissue and their effects on the development and prognosis of ovarian cancers
    Akyurek, E. N.
    Avsar, A. F. Yavuz
    Ural, U. M.
    Kilicarslan, A.
    Yildirim, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (05) : 675 - 679
  • [27] p53, Bcl-2 and AgNOR Tissue Markers: Model Approach in Predicting Prostate Cancer Characteristics
    Munda, M.
    Hajdinjak, T.
    Kavalar, R.
    Martincic, D. Stiblar
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (06) : 1868 - 1876
  • [28] Loss of Bcl-2 expression impacts survival in colorectal cancer using a high throughput tissue microarray analysis (AQUA)
    Nicholson, Allen
    Guo, Xiaojia
    Sullivan, Catherine
    Cha, Charles
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (03) : S127 - S127
  • [29] Prognostic significance of immunohistochemical expression of bcl-2, p53 and ki67 in early operable non-small cell lung cancer
    Tsobanidou, Xristina
    Boukovinas, Ioannis
    Papageorgiou, Athanasios
    Anestakis, Dimitrios
    Barbetakis, Nikolaos
    Papakotoulas, Pavlos
    Xenidis, Nikolaos
    Ligdas, Athanasios
    Toliou, Theofano
    ANNALS OF ONCOLOGY, 2006, 17 : 253 - 253
  • [30] Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma
    Keshgegian, AA
    Johnston, E
    Cnaan, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (04) : 443 - 449
12345